High-dose VP-16-213 monotherapy for refractory germinal malignancies: A phase II study

S. N. Wolff, D. H. Johnson, J. D. Hainsworth, F. A. Greco

Research output: Contribution to journal › Article › peer-review

59 Scopus citations